Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 48,900Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Brukinsa

PharmaCompass

01

Brand Name : Brukinsa

Zanubrutinib

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Brukinsa

arrow
euroPLX 86 Munich
Not Confirmed

Zanubrutinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 240

2020 Revenue in Millions : 45

Growth (%) : 423

blank

02

Brand Name : Brukinsa

Zanubrutinib

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Brukinsa

arrow
euroPLX 86 Munich
Not Confirmed

Zanubrutinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 595

2021 Revenue in Millions : 240

Growth (%) : 148

blank

03

Brand Name : Brukinsa

Zanubrutinib

arrow
euroPLX 86 Munich
Not Confirmed

Brand Name : Brukinsa

arrow
euroPLX 86 Munich
Not Confirmed

Zanubrutinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1,396

2022 Revenue in Millions : 595

Growth (%) : 129

blank